LRMR Stock-Based Compensation

Larimar Therapeutics Inc · Stock-Based Compensation

LRMR logo

LRMR Stock-Based Compensation

Latest reported$7.47M
LRMR TTM Stock-Based Comp ($8.58M → $7.47M)
High-resolution chart · PNG

LRMR stock-based compensation history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Larimar Therapeutics Inc Stock-Based Compensation — Trailing twelve months (TTM) (USD)
Period endingStock-Based Compensation (USD)
7,470,000
7,149,000
7,004,000
7,857,000
8,029,000
8,502,000
8,796,000
8,304,000
8,168,000
7,910,000
7,615,000
7,340,000
7,185,000
6,817,000
6,619,000
6,456,000
6,253,000
5,928,000
5,473,000
5,003,000
3,910,000
3,312,000
2,161,000
1,151,000
814,000
95,000
100,000
7,261,000
7,228,000
9,661,000
7,626,000
2,466,000
-290,000
0
9,526,000
8,582,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.